Suchergebnisse - "Lenz, Oliver"

PubPharm (507)

1

The energy metabolism ofCupriavidus necatorin different trophic conditions

enthalten in: bioRxiv.org | 2024

von Jahn, M. | Crang, N. | Gynnå, A. | +5

2

Chronic Hepatitis B Finite Treatment : Similar and Different Concerns With New Drug Classes

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2024

von Peters, M. | Yuen, M. | Terrault, N. | +16

3

JNJ-73763989 and bersacapavir treatment in nucleos(t)ide analog suppressed patients with chronic hepatitis B : REEF-2

enthalten in: Journal of hepatology | 2024

von Agarwal, K. | Buti, M. | van Bömmel, F. | +14

4

Chemoorganotrophic electrofermentation by Cupriavidus necator using redox mediators

enthalten in: Bioelectrochemistry (Amsterdam, Netherlands) | 2024

von Gemünde, A. | Rossini, E. | Lenz, O. | +2

5

Prevalence of hepatitis D virus antibody positivity in Chinese patients with chronic hepatitis B virus infection

enthalten in: ResearchSquare.com | 2023

von Liang, X. | Tang, H. | Guan, Y. | +14

6

Stepwise conversion of the Cys6[4Fe-3S] to a Cys4[4Fe-4S] cluster and its impact on the oxygen tolerance of [NiFe]-hydrogenase

enthalten in: Chemical science | 2023

von Schmidt, A. | Kalms, J. | Lorent, C. | +10

7

Efficacy and safety of the siRNA JNJ-73763989 and the capsid assembly modulator JNJ-56136379 (bersacapavir) with nucleos(t)ide analogues for the treatment of chronic hepatitis B virus infection (REEF-1) : a multicentre, double-blind, active-controlled, randomised, phase 2b trial

enthalten in: The lancet. Gastroenterology & hepatology | 2023

von Yuen, M. | Asselah, T. | Jacobson, I. | +116

CommentIn: Lancet Gastroenterol Hepatol. 2023 Sep;8(9):772-773. - PMID 37442151

8

HDV RNA assays : Performance characteristics, clinical utility, and challenges

enthalten in: Hepatology (Baltimore, Md.) | 2023

von Wedemeyer, H. | Leus, M. | Battersby, T. | +15

9

Viral sequence analysis of chronic hepatitis B patients treated with the capsid assembly modulator JNJ-56136379 in the JADE phase 2a study

enthalten in: Antiviral research | 2023

von Verbinnen, T. | Talloen, W. | Janssen, H. | +6

10

Randomised phase 2 study (JADE) of the HBV capsid assembly modulator JNJ-56136379 with or without a nucleos(t)ide analogue in patients with chronic hepatitis B infection

enthalten in: Gut | 2023

von Janssen, H. | Hou, J. | Asselah, T. | +16

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[51]